Company: HURA
Filing Date: 2025-06-30
Form Type: 8-K
Source: 0000950170-25-091693
Chunk: 1

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-06-30
Form: 8-K
Item: Item 2.01
Chunk 1
---
 the closing of the Mergers, and (ii) the right to its pro rata share of cash consideration received by Kineta pursuant to disposed asset payments related to legacy Kineta assets. Such payments, if any, will be made at a later date and in accordance with the terms of the Merger Agreement. In each case, in lieu of the issuance of any fractional shares of TuHURA Common Stock, TuHURA will pay an amount equal to the product of (A) such fractional share and (B) $5.7528.

The foregoing summary of the Merger Agreement is not complete and is qualified in its entirety by reference to the full text of the Merger Agreement, which is attached as Exhibits 2.1 and 2.2 to this Current Report on Form 8-K (this “ Current Report”) and is incorporated by reference in its entirety.